Exeliom Biosciences products

Faecalibacterium prausnitzii (F. prau), a key bacterium to treat Crohn’s Disease Meet Faecalibacterium prausnitzii (F. prau) WHAT IS F. prau? F. prau, is a dominant member of the healthy gut microbiome. It accounts for 5% to 15% of the total fecal microbiome in healthy adults, which is simply colossal. F. prau is the most extreme example of strict anaerobic bacteria. In other words, F. prau simply cannot stand oxygen exposure as it has naturally thrived throughout evolution in our gut in total absence of oxygen.

Our research has led us to discover that patients suffering from inflammatory bowel diseases lack a crucial bacterium and, therefore, do not have a fair chance to fight their conditions. We have developed a single bacterial strain drug candidate to deliver the key bacteria Faecalibacterium praustnizii for the treatment of inflammatory bowel diseases, starting with Crohn`s Disease as a first indication.